Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Apnimed's experimental drug reduced breathing interruptions by nearly 46.8% in clinical trials, offering a potential ...

Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

When Zepbound, Eli Lilly's highly anticipated weight ... sleep apnea. But a recent coverage change by a major pharmacy benefit manager may force many to decide how much they're willing to pay for the ...

It isn’t. "Medications like Ozempic lead to weight loss, which helps to improve sleep apnea," explains Brian Wojeck, MD, MPH, an endocrinologist at Yale Medicine in New Haven, Connecticut.

Mounjaro (tirzepatide), a weight-loss injection, is now approved to treat moderate-to-severe obstructive sleep apnea in obese adults, offering a breakthrough option beyond CPAP therapy, despite ...

As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ...